Both autoimmune diseases presented a high number of common proteins involved in the development of T1DM and MS; however, our results have identified two specific proteins with significant profile changes compared with those in the healthy population, and with a potential diagnostic value for differentiating both pathologies: CSTB and RASSF2. Here, CSTB is linked to myeloid sarcoma.